Rimactane and hepatitis fulminant Patient Reports February 12, 2012

Rimactane Side Effects Report #5050825-7
Rimactane side effect was reported by a Physician from JAPAN on June 27, 2006. Male patient, 66 years of age, was diagnosed with pulmonary tuberculosis and was treated with Rimactane. After drug was administered, patient experienced the following side effects: haemodialysis, hepatic failure, hepatitis fulminant, somnolence, white blood cell count decreased. Rimactane dosage: 300 MG, ORAL. During the same period patient was treated with ISONIAZID, PYRAZINAMIDE, ETHAMBUTOL, ADEROXAL. Patient died on 05/21/2006.

Rimactane Side Effects Report #5259057-0
Rimactane side effect was reported by a Physician from JAPAN on Feb 21, 2007. Female patient, 75 years of age, weighting 72.75 lb, was diagnosed with mycobacterial infection and was treated with Rimactane. After drug was administered, patient experienced the following side effects: blood glucose decreased, blood pressure decreased, cardio-respiratory arrest, condition aggravated, disseminated intravascular coagulation, haemolytic anaemia, hepatitis fulminant, loss of consciousness, melaena. Rimactane dosage: 450 MG, ORAL. During the same period patient was treated with ETHAMBUTOL HYDROCHLORIDE, CLARITHROMYCIN, MUCODYNE, GLORIAMIN, PURSENNID, KAMAG G, JUZENTAIHOTO, UNASYN. Patient was hospitalized. Patient died on 10/09/2006.

Rimactane Side Effects Report #5141104-8
Rimactane side effect was reported by a Physician from JAPAN on Oct 19, 2006. Female patient was diagnosed with mycobacterial infection and was treated with Rimactane. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, haemolytic anaemia, hepatitis fulminant. Rimactane dosage: 450 MG, ORAL. Patient was hospitalized. Patient died.